Interest in pulmonary delivery of drugs is increasing for both acute and systemic disease conditions. Particle engineering via spray drying is an enabling technology for a number of new API’s destined for lung delivery. Process and formulation attributes are tunable for either small or large molecules, range of API physical properties, and / or desired delivery platform. Robust spray drying approaches have been developed to ensure phase-appropriate formulation development with streamlined timelines and costs. Encapsulation of spray-dried formulations can further enhance speed-to-clinic through commercialization.
During this webinar, we will discuss how target product properties and profiles can be met by altering process conditions and excipient selection for inhalable dry powders.
We will further discuss: